Oct. 16 (Bloomberg) -- IK Investment Partners, a European buyout firm, hired four banks to provide less than 100 million euros ($130 million) of loans for its buyout of Vemedia Pharma NV, according to two people with knowledge of the matter.
Belfius Bank NV, Deutsche Bank AG, Fortis Bank SA/NV, and ING Groep NV provided the financing for the acquisition that values Kortrijk, Belgium-based Vemedia Pharma at about 138 million euros, said the people, who asked not to be identified because the deal is private.
IK Investment said yesterday it agreed to buy a majority stake in the supplier of over-the-counter medicines and will make a cash offer for the remaining securities it doesn’t own at 2.80 euros per share.
Charlotte Laveson, a spokeswoman in London for IK Investment, declined to comment on the debt financing.
To contact the reporter on this story: Patricia Kuo in London at firstname.lastname@example.org
To contact the editor responsible for this story: Faris Khan at email@example.com